IBC's 6th Annual Targeting Metabolic Disorders (formerly Targeting Metabolic Syndrome) is a must-attend conference each year for preclinical and clinical stage research scientists developing metabolic and cardiovascular disease therapeutics – and for academic researchers working in the field.